CraniUS Therapeutics: Series BDevelops implantable platform to bypass blood-brain barrier for drug deliveryOct 4, 2026RoundOSCraniUS TherapeuticsCompany profile and funding historySourcesprnewswire.comMore in HealthtechMetriport · Series AProFound Therapeutics · StrategicArintra · Series BUnited StatesHealthtechNorth AmericaSeries B